Enhanced behavioral sensitivity to the competitive GABA agonist, gaboxadol, in transgenic mice over-expressing hippocampal extrasynaptic [alpha]6[beta] GABA(A) receptors

"The behavioral and functional significance of the extrasynaptic inhibitory GABA(A) receptors in the brain is still poorly known. We used a transgenic mouse line expressing the GABA(A) receptor alpha 6 subunit gene in the forebrain under the Thy-1.2 promoter (Thy1 alpha 6) mice ectopically expressing alpha 6 subunits especially in the hippocampus to study how extrasynaptically enriched alpha beta(gamma 2)-type receptors alter animal behavior and receptor responses. In these mice extrasynaptic alpha 6 beta receptors make up about 10% of the hippocampal GABA(A) receptors resulting in imbalance between synaptic and extrasynaptic inhibition. The synthetic GABA-site competitive agonist gaboxadol (4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol; 3 mg/kg) induced remarkable anxiolytic-like response in the light : dark exploration and elevated plus-maze tests in Thy1 alpha 6 mice, while being almost inactive in wild-type mice. The transgenic mice also lost quicker and for longer time their righting reflex after 25 mg/kg gaboxadol than wild-type mice. In hippocampal sections of Thy1 alpha 6 mice, the alpha 6 beta receptors could be visualized autoradiographically by interactions between gaboxadol and GABA via [S-35]TBPS binding to the GABA(A) receptor ionophore. Gaboxadol inhibition of the binding could be partially prevented by GABA. Electrophysiology of recombinant GABA(A) receptors revealed that GABA was a partial agonist at alpha 6 beta 3 and alpha 6 beta 3 delta receptors, but a full agonist at alpha 6 beta 3 gamma 2 receptors when compared with gaboxadol. The results suggest strong behavioral effects via selective pharmacological activation of enriched extrasynaptic alpha beta GABA(A) receptors, and the mouse model represents an example of the functional consequences of altered balance between extrasynaptic and synaptic inhibition."